Recent Update on PCSK9 and Platelet Activation Experimental Research Methods: In Vitro and In Vivo Studies

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a crucial factor in the development and progression of cardiovascular diseases. PCSK9 has been demonstrated to modify LDL plasma levels and increase platelet activation, which promotes atherosclerosis, a defining feature of nearly all cardiova...

Descripción completa

Detalles Bibliográficos
Autores principales: Puteri, Meidi Utami, Azmi, Nuriza Ulul, Ridwan, Salbiah, Iqbal, Muhammad, Fatimah, Tresni, Rini, Tri Diana Puspita, Kato, Mitsuyasu, Saputri, Fadlina Chany
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409389/
https://www.ncbi.nlm.nih.gov/pubmed/36005422
http://dx.doi.org/10.3390/jcdd9080258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409389/
https://www.ncbi.nlm.nih.gov/pubmed/36005422
http://dx.doi.org/10.3390/jcdd9080258

Ejemplares similares